Revelation Biosciences, Inc.
REVB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$15,039 | -$120 | -$10,830 | -$11,987 |
| Dep. & Amort. | $28 | $25 | $25 | $17 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $169 | $156 | $301 | $471 |
| Change in WC | -$3,423 | $982 | -$731 | $356 |
| Other Non-Cash | -$56 | -$8,329 | $15 | $52 |
| Operating Cash Flow | -$18,321 | -$7,286 | -$11,219 | -$11,091 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$19 | $0 | $0 | -$132 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $525 |
| Other Inv. Act. | $0 | $0 | $0 | -$525 |
| Investing Cash Flow | -$19 | $0 | $0 | -$132 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | -$797 | $0 |
| Stock Issued | $12,848 | $14,030 | $4,451 | $600 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$5 | $11,543 | $7,405 |
| Financing Cash Flow | $12,848 | $14,025 | $15,198 | $8,005 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$5,493 | $6,739 | $3,978 | -$3,218 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $11,992 | $5,253 | $1,275 | $4,492 |
| End Cash | $6,499 | $11,992 | $5,253 | $1,275 |
| Free Cash Flow | -$18,340 | -$7,286 | -$11,219 | -$11,223 |